
Sign up to save your podcasts
Or
Following promising results from Pfizer and Moderna, why is a third vaccine, from Oxford University and AstraZeneca, so important in the fight against covid-19? Host Kenneth Cukier and The Economist’s health policy editor Natasha Loder investigate the different approaches to this immense challenge. And Nicholas Christakis, a doctor and network scientist at Yale University, explains how despite a vaccine the pandemic could change humanity for good.
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.
4.8
570570 ratings
Following promising results from Pfizer and Moderna, why is a third vaccine, from Oxford University and AstraZeneca, so important in the fight against covid-19? Host Kenneth Cukier and The Economist’s health policy editor Natasha Loder investigate the different approaches to this immense challenge. And Nicholas Christakis, a doctor and network scientist at Yale University, explains how despite a vaccine the pandemic could change humanity for good.
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.
4,275 Listeners
526 Listeners
916 Listeners
366 Listeners
99 Listeners
224 Listeners
106 Listeners
2,540 Listeners
45 Listeners
1,080 Listeners
1,430 Listeners
137 Listeners
116 Listeners
101 Listeners
36 Listeners
890 Listeners
345 Listeners
498 Listeners
81 Listeners
68 Listeners
115 Listeners
101 Listeners
203 Listeners